ResearcherIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale"No recent work listed

Francesco Perrone

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9738-0526; OpenAlex author ID A5102804100. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2021: 1 paper

Papers 1

Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomi… Last author DOI 10.1016/j.ejca.2021.02.023 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Andrea Spallanzani · 1 shared paper, 2021 · strength 0.09
- Paper Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancr… DOI 10.1016/j.ejca.2021.02.023 ↗
Roberto Labianca · 1 shared paper, 2021 · strength 0.09
- Paper Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancr… DOI 10.1016/j.ejca.2021.02.023 ↗
Alessandro Bittoni · 1 shared paper, 2021 · strength 0.09
- Paper Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancr… DOI 10.1016/j.ejca.2021.02.023 ↗
Stefania Mosconi · 1 shared paper, 2021 · strength 0.09
- Paper Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancr… DOI 10.1016/j.ejca.2021.02.023 ↗
Ciro Gallo · 1 shared paper, 2021 · strength 0.09
- Paper Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancr… DOI 10.1016/j.ejca.2021.02.023 ↗
Rossana Berardi · 1 shared paper, 2021 · strength 0.09
- Paper Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancr… DOI 10.1016/j.ejca.2021.02.023 ↗
Roberto Bianco · 1 shared paper, 2021 · strength 0.09
- Paper Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancr… DOI 10.1016/j.ejca.2021.02.023 ↗
Alberto Zaniboni · 1 shared paper, 2021 · strength 0.09
- Paper Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancr… DOI 10.1016/j.ejca.2021.02.023 ↗
Stefano Cascinu · 1 shared paper, 2021 · strength 0.09
- Paper Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancr… DOI 10.1016/j.ejca.2021.02.023 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.